Scholarlink

This was the case with non-small cell lung cancer who developed severe anorexia, nausea, and vomiting with significant weight loss related to nivolumab. His initial episode resolved with intravenous acid suppression therapy and steroids, but he had multiple subsequent recurrences and hospitalizations on steroid taper. EGD demonstrated persistent moderate inflammation on multiple follow ups. Ultimately, the patient received vedolizumab and had complete resolution of his symptoms. Cancer therapy was not resumed given remission of his disease, and the patient passed away years later due to unrelated causes.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Upper Gastrointestinal Toxicity Following Immune Checkpoint Inhibitor Therapy

  • 章节

  • 发表日期：

    2025年

查看全文
  • Malek Shatila,
  • Krishnavathana Varatharajalu,
  • Mehnaz A. Shafi,
  • Anusha S. Thomas,
  • Yinghong Wang

摘要

This was the case with non-small cell lung cancer who developed severe anorexia, nausea, and vomiting with significant weight loss related to nivolumab. His initial episode resolved with intravenous acid suppression therapy and steroids, but he had multiple subsequent recurrences and hospitalizations on steroid taper. EGD demonstrated persistent moderate inflammation on multiple follow ups. Ultimately, the patient received vedolizumab and had complete resolution of his symptoms. Cancer therapy was not resumed given remission of his disease, and the patient passed away years later due to unrelated causes.